When 1+1 = 3: Unlocking the potential of the IL-2 pathway with NKTR-214 in combination treatment

Date 15 December 2018
Event ESMO Immuno-Oncology Congress 2018
Session Immuno-oncology: State of the art I
Topics Biological Therapy
Therapy
Presenter Jonathan Zalevsky
Authors J. Zalevsky
  • Biology, Nektar Therapeutics, 94158 - San Francisco/US